Screening for prostate cancer: an update of the evidence for the U.S. Preventive Services Task Force
about
sameAs
Screening for prostatic cancerA glossary for evidence based public healthDifferences between men with screening-detected versus clinically diagnosed prostate cancers in the USALack of comprehension of common prostate cancer terms in an underserved population.Shared decision making for prostate cancer screening: the results of a combined analysis of two practice-based randomized controlled trials.Interpreting data from randomized trials: the Scandinavian prostatectomy study illustrates two common errors.The roulette wheel: an aid to informed decision making.Population based prostate cancer screening in north Mexico reveals a high prevalence of aggressive tumors in detected cases.Entertainment education for prostate cancer screening: a randomized trial among primary care patients with low health literacy.Use of the prostate-specific antigen test among men aged 75 years or older in the United States: 2006 Behavioral Risk Factor Surveillance System.Novel diagnostic biomarkers for prostate cancer.A tissue biopsy-based epigenetic multiplex PCR assay for prostate cancer detectionPerceived ambiguity about cancer prevention recommendations: relationship to perceptions of cancer preventability, risk, and worryGSTP1 CpG island hypermethylation as a molecular biomarker for prostate cancer.The Japanese guideline for prostate cancer screening.Annual report to the nation on the status of cancer, 1975-2004, featuring cancer in American Indians and Alaska Natives.A test of knowledge about prostate cancer screening. Online pilot evaluation among Southern California Physicians.Prostate and colon cancer screening messages in popular magazinesInternational epidemiology of prostate cancer: geographical distribution and secular trends.Cancer risk assessment for the primary care physician.The stadium diagram, a web-based tool for visualizing the expected outcomes of alternative clinical management strategiesUS men discussing prostate-specific antigen tests with a physician.Clinically localised prostate cancer.Screening for prostate cancer: have you had your cholesterol measured?Racial/ethnic differences in predictors of PSA screening in a tri-ethnic population.Translating medical evidence to promote informed health care decisions.The use of gene tests to detect hereditary predisposition to chronic disease: is cost-effectiveness analysis relevant?Informed decision making: what is its role in cancer screening?Older age and liver transplantation: a review.Screening for cancer: valuable or not?Assigning ambulatory patients and their physicians to hospitals: a method for obtaining population-based provider performance measurements.Current Challenges in Prostate Cancer Management and the Rationale behind Targeted Focal Therapy.MRI-guided focal therapy of prostate cancer.Cost analysis of screening for, diagnosing, and staging prostate cancer based on a systematic review of published studiesProstate cancer screening trends in a large, integrated health care system.Prostate cancer, the PSA test and academic detailing in Australian general practice: an economic evaluation.Cancer biomarkers: knowing the present and predicting the future.Nonmedical information seeking amid conflicting health information: negative and positive effects on prostate cancer screening.The impact of a suspicious prostate biopsy on patients' psychological, socio-behavioral, and medical care outcomes.Prostate cancer testing following a negative prostate biopsy: over testing the elderly
P2860
Q24247276-00E423FB-80B2-49C6-B483-8DFBB3DF0D53Q24682591-89E6BF71-CE98-40D6-AAA5-5F81FCCD64A6Q24805151-5064C0E8-42BB-45C0-AC22-F998A7601634Q30436410-2B02D2E0-BC0A-41C7-8E74-59F6A230D554Q30536703-B3617021-265F-485A-8B3D-1B557707DFF2Q31032294-E9AFEBFE-F74B-4D0F-ACE6-F71E3865FBFBQ33245714-1F19E52E-38E0-432A-A779-A38EC5691782Q33421572-8986D17A-A3CB-4931-904E-168D6FB2774DQ33840211-66D646CC-B273-4A96-8FBF-EB62CCAD0426Q33982806-2D1ECE99-BE8A-4F2C-BA0C-60FC7F90B75CQ34231678-95DC5F37-784F-45D8-A541-2C81915B31CFQ34294196-B197DA6C-CA27-4A7A-9826-413F2ED2BA26Q34324409-E85C35E9-78A1-4918-9AEC-AD3FD9338F8AQ34544893-7C892ABE-C3CD-407C-B90A-E61C854AD153Q34606240-2A053DBC-6A8E-4C02-AA34-B68D4755A17AQ34701416-92ADEF5D-E9D6-4EC6-BA04-514DB9DEE0DCQ34704735-484194C6-ABEA-4182-8853-822AD05ACD3FQ34733365-E2FD16DD-7638-4280-88F6-38939F645D20Q34909339-8FEAA886-8189-454F-BA5D-020156149E43Q34992880-33584685-6B0D-4019-AE00-7EDC6FC5211EQ35018303-A3485BDD-8DAC-41EE-BF42-3D8A642E37CAQ35052458-6721E472-91A7-49F0-8D23-6094BF5E37E4Q35166972-9AF0C41D-CB06-418C-982D-1AD359D0B872Q35187517-E5E70187-31B0-49BC-9F70-A9CEE962A7ECQ35189835-5BF43178-6514-41C8-AC4B-1F2781C46410Q35191000-9EE6F1BF-98BD-4327-96AB-486AE158F296Q35564692-A2506716-E59A-4924-9A79-E46A51E98C70Q35865874-7B263103-9D39-4ABB-BEE4-265C997A0023Q35897423-2118DED5-18B9-4424-97C5-B23ECC13B19BQ35918882-A7297300-6041-4D1D-8775-B22E2B069C42Q35956597-AFC545C2-0FD1-4834-AB71-DFFE8EEBE7A1Q35977609-8C9DC287-04CA-4EE7-84B8-1610E99E99EDQ36173279-38771ACD-1AC8-4D36-B0C4-AE75DCCBBEB6Q36176742-77A6B9A1-E83A-4293-A0E7-C85E91FA9AB4Q36235155-773648DC-F16C-4BDB-8B8C-447F7ABCC36BQ36285410-FF9CCEA4-5669-4B4E-B3A7-0C07CF3C7640Q36429381-4D02C9FE-9BEE-44C6-8C83-A26FEF93FB59Q36436602-5D2532B8-11E4-44DD-BAC8-F97D79F4180EQ36523352-43E6CFBC-266F-4173-8864-92CC0FD27FC7Q36552040-A723F9E4-96C6-4D9E-9DE8-7271E5933A5D
P2860
Screening for prostate cancer: an update of the evidence for the U.S. Preventive Services Task Force
description
2002 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2002
@ast
im Dezember 2002 veröffentlichter wissenschaftlicher Artikel
@de
scientific article (publication date: 3 December 2002)
@en
vedecký článok (publikovaný 2002/12/03)
@sk
vědecký článek publikovaný v roce 2002
@cs
wetenschappelijk artikel (gepubliceerd op 2002/12/03)
@nl
наукова стаття, опублікована в грудні 2002
@uk
مقالة علمية (نشرت في 3-12-2002)
@ar
name
Screening for prostate cancer: ...... Preventive Services Task Force
@ast
Screening for prostate cancer: ...... Preventive Services Task Force
@en
Screening for prostate cancer: ...... Preventive Services Task Force
@nl
type
label
Screening for prostate cancer: ...... Preventive Services Task Force
@ast
Screening for prostate cancer: ...... Preventive Services Task Force
@en
Screening for prostate cancer: ...... Preventive Services Task Force
@nl
prefLabel
Screening for prostate cancer: ...... Preventive Services Task Force
@ast
Screening for prostate cancer: ...... Preventive Services Task Force
@en
Screening for prostate cancer: ...... Preventive Services Task Force
@nl
P1476
Screening for prostate cancer: ...... Preventive Services Task Force
@en
P2093
Kathleen N Lohr
Russell Harris
P304
P356
10.7326/0003-4819-137-11-200212030-00014
P407
P577
2002-12-03T00:00:00Z